Page last updated: 2024-08-24

imiquimod and Lymphoma, Large-Cell, Anaplastic

imiquimod has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagli, L; Calista, D; Riccioni, L; Valenzano, F	1

Other Studies

1 other study(ies) available for imiquimod and Lymphoma, Large-Cell, Anaplastic

Article	Year
Long-term remission of primary cutaneous neutrophil-rich CD30+ anaplastic large cell lymphoma treated with topical imiquimod. A case report. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:5 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Remission Induction	2016

Article

Year

Long-term remission of primary cutaneous neutrophil-rich CD30+ anaplastic large cell lymphoma treated with topical imiquimod. A case report.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:5

Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Remission Induction

2016